These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 35108595)
1. Development of magnetic particle-based chemiluminescence immunoassay for measurement of SARS-CoV-2 nucleocapsid protein. Xu Y; Xia C; Zeng X; Qiu Y; Liao M; Jiang Q; Quan M; Liu R J Virol Methods; 2022 Apr; 302():114486. PubMed ID: 35108595 [TBL] [Abstract][Full Text] [Related]
3. Sensitive and specific enzyme-linked immunosorbent assay using chemiluminescence for detection of severe acute respiratory syndrome viral infection. Fujimoto K; Chan KH; Takeda K; Lo KF; Leung RH; Okamoto T J Clin Microbiol; 2008 Jan; 46(1):302-10. PubMed ID: 18032623 [TBL] [Abstract][Full Text] [Related]
4. Preparation of highly specific monoclonal antibodies against SARS-CoV-2 nucleocapsid protein and the preliminary development of antigen detection test strips. Xie C; Ding H; Ding J; Xue Y; Lu S; Lv H J Med Virol; 2022 Apr; 94(4):1633-1640. PubMed ID: 34904253 [TBL] [Abstract][Full Text] [Related]
5. Monoclonal Antibodies against Nucleocapsid Protein of SARS-CoV-2 Variants for Detection of COVID-19. Lu RM; Ko SH; Chen WY; Chang YL; Lin HT; Wu HC Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830291 [TBL] [Abstract][Full Text] [Related]
6. Accuracy of a nucleocapsid protein antigen rapid test in the diagnosis of SARS-CoV-2 infection. Diao B; Wen K; Zhang J; Chen J; Han C; Chen Y; Wang S; Deng G; Zhou H; Wu Y Clin Microbiol Infect; 2021 Feb; 27(2):289.e1-289.e4. PubMed ID: 33031947 [TBL] [Abstract][Full Text] [Related]
7. Design and Development of an Antigen Test for SARS-CoV-2 Nucleocapsid Protein to Validate the Viral Quality Assurance Panels. Ray P; Ledgerwood-Lee M; Brickner H; Clark AE; Garretson A; Graham R; Van Zant W; Carlin AF; Aronoff-Spencer ES Viruses; 2024 Apr; 16(5):. PubMed ID: 38793544 [TBL] [Abstract][Full Text] [Related]
8. Evaluations of the serological test in the diagnosis of 2019 novel coronavirus (SARS-CoV-2) infections during the COVID-19 outbreak. Lin D; Liu L; Zhang M; Hu Y; Yang Q; Guo J; Dai Y; Xu Y; Cai Y; Chen X; Huang K; Zhang Z Eur J Clin Microbiol Infect Dis; 2020 Dec; 39(12):2271-2277. PubMed ID: 32681308 [TBL] [Abstract][Full Text] [Related]
9. N-terminally truncated nucleocapsid protein of SARS-CoV-2 as a better serological marker than whole nucleocapsid protein in evaluating the immunogenicity of inactivated SARS-CoV-2. Yue L; Cao H; Xie T; Long R; Li H; Yang T; Yan M; Xie Z J Med Virol; 2021 Mar; 93(3):1732-1738. PubMed ID: 32965677 [TBL] [Abstract][Full Text] [Related]
11. Rapid Biosensor of SARS-CoV-2 Using Specific Monoclonal Antibodies Recognizing Conserved Nucleocapsid Protein Epitopes. Lee JH; Jung Y; Lee SK; Kim J; Lee CS; Kim S; Lee JS; Kim NH; Kim HG Viruses; 2022 Jan; 14(2):. PubMed ID: 35215848 [TBL] [Abstract][Full Text] [Related]
12. Characterization and application of a series of monoclonal antibodies against SARS-CoV-2 nucleocapsid protein. Zhou L; Mo C; Yang Y; Zhou Z; You A; Fan Y; Liu W; Li X; Zhou R; Tian X J Med Virol; 2023 Jan; 95(1):e28225. PubMed ID: 36238992 [TBL] [Abstract][Full Text] [Related]
13. Voltammetric-based immunosensor for the detection of SARS-CoV-2 nucleocapsid antigen. Eissa S; Alhadrami HA; Al-Mozaini M; Hassan AM; Zourob M Mikrochim Acta; 2021 May; 188(6):199. PubMed ID: 34041585 [TBL] [Abstract][Full Text] [Related]
14. The development of a highly sensitive and quantitative SARS-CoV-2 rapid antigen test applying newly developed monoclonal antibodies to an automated chemiluminescent flow-through membrane immunoassay device. Nishimura K; Kitazawa H; Kawahata T; Yuhara K; Masuya T; Kuroita T; Waki K; Koike S; Isobe M; Kurosawa N BMC Immunol; 2023 Sep; 24(1):34. PubMed ID: 37752417 [TBL] [Abstract][Full Text] [Related]
15. Magnetic particle-based chemiluminescence immunoassay for serum human heart-type fatty acid binding protein measurement. Zheng J; Qiu Y; Xu Y; Quan M; Zhong Z; Wang Q; Wu Y; Zeng X; Xia C; Liu R Biotechnol Lett; 2023 Dec; 45(11-12):1431-1440. PubMed ID: 37736778 [TBL] [Abstract][Full Text] [Related]
16. [Development and application of triple antibodies-based sandwich ELISA for detecting nucleocapsid protein of SARS-associated coronavirus]. Qiu LW; Tang HW; Wang YD; Liao JE; Hao W; Wen K; He XM; Che XY Zhonghua Liu Xing Bing Xue Za Zhi; 2005 Apr; 26(4):277-81. PubMed ID: 15941537 [TBL] [Abstract][Full Text] [Related]
17. Lateral Flow Immunoassay Coupled with Copper Enhancement for Rapid and Sensitive SARS-CoV-2 Nucleocapsid Protein Detection. Peng T; Jiao X; Liang Z; Zhao H; Zhao Y; Xie J; Jiang Y; Yu X; Fang X; Dai X Biosensors (Basel); 2021 Dec; 12(1):. PubMed ID: 35049641 [TBL] [Abstract][Full Text] [Related]
18. Expression, purification and immunological characterization of recombinant nucleocapsid protein fragment from SARS-CoV-2. Djukic T; Mladenovic M; Stanic-Vucinic D; Radosavljevic J; Smiljanic K; Sabljic L; Devic M; Cujic D; Vasovic T; Simovic A; Radomirovic M; Cirkovic Velickovic T Virology; 2021 May; 557():15-22. PubMed ID: 33582454 [TBL] [Abstract][Full Text] [Related]
19. Ultrasensitive and Simultaneous Detection of Two Specific SARS-CoV-2 Antigens in Human Specimens Using Direct/Enrichment Dual-Mode Fluorescence Lateral Flow Immunoassay. Wang C; Cheng X; Liu L; Zhang X; Yang X; Zheng S; Rong Z; Wang S ACS Appl Mater Interfaces; 2021 Sep; 13(34):40342-40353. PubMed ID: 34412466 [TBL] [Abstract][Full Text] [Related]